Insilico Medicine Inc

Insilico Medicine Inc. develops biotechnology solutions focused on AI-driven drug discovery and development. The company advances clinical candidates for fibrosis, cancer, immunology, and aging, and commercializes generative AI platforms for research. It serves pharmaceutical companies and academic institutions in Greater China, the Middle East, and the US.